These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3473154)

  • 1. A 60 kilodalton oncofetal protein as tumor marker.
    Hanausek-Walaszek M; Walaszek Z; Webb TE
    J Med; 1986; 17(1):13-23. PubMed ID: 3473154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental changes in expression of a tumor-associated protein in the rat fetus.
    Runge SW; Larroya S; Schumm DE; Webb TE
    J Cell Biochem; 1989 Nov; 41(3):135-7. PubMed ID: 2613749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of the cancer-associated factor with a molecular weight of 60,000 from the plasma of patients with a spectrum of nonneoplastic conditions.
    Schumm DE; Hanausek-Walaszek ME; Walaszek Z; Webb TE
    Cancer Res; 1984 Jan; 44(1):401-6. PubMed ID: 6690055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncofetal antigen-I: distribution in human tumors.
    Rees WV; Irie RF; Morton DL
    J Natl Cancer Inst; 1981 Sep; 67(3):557-62. PubMed ID: 6268878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of oncofetal protein-related mRNA transport activity as a potential early cancer marker in dogs with malignant neoplasms.
    Stromberg PC; Schumm DE; Webb TE; Ward H; Couto CG
    Am J Vet Res; 1995 Dec; 56(12):1559-63. PubMed ID: 8599514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pancreatic oncofetal antigen (POA)].
    Mugitani H; Furue H; Kako M; Hirota F; Fuse K; Takahashi T; Sakamoto K; Yamada K; Suminaga M; Ezaki M; Judo R
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1737-43. PubMed ID: 6882002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
    Esheba GE; Pate LL; Longacre TA
    Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of oncofetal antigens in cancer.
    Wepsic HT
    Ann Clin Lab Sci; 1983; 13(4):261-6. PubMed ID: 6194734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correspondence between biochemical and antigenic activity of a 60 kilodalton oncofetal protein during carcinogenesis and tumorigenesis.
    Hanausek-Walaszek M; Montgomery N; Walaszek Z; Long RW; Webb TS
    Cancer Lett; 1986 Oct; 33(1):55-61. PubMed ID: 2429761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interspecific embryonic antigens in the blood serum of cancer patients].
    Kalashnikov VV; Chekhonin VP; Tatarinov IuS
    Vopr Onkol; 1983; 29(4):24-9. PubMed ID: 6858045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The present status of immunodiagnosis and immunotherapy of cancer.
    Pasternak G
    Arch Geschwulstforsch; 1981; 51(4):284-93. PubMed ID: 7032448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of the mouse stage-specific embryonic antigen 1 in human tissues and tumors.
    Fox N; Damjanov I; Knowles BB; Solter D
    Cancer Res; 1983 Feb; 43(2):669-78. PubMed ID: 6129058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GM-CSF expression by tumor cells correlates with aggressivity and with stroma reaction formation.
    Bretscher V; Andreutti D; Neuville P; Martin M; Martin F; Lefebvre O; Gilles C; Benzonana G; Gabbiani G
    J Submicrosc Cytol Pathol; 2000 Oct; 32(4):525-33. PubMed ID: 11297371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
    Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
    Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.
    Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL
    Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of pancreatic oncofetal antigen (POA) in the diagnosis of pancreatic cancer].
    Nishida K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):601-8. PubMed ID: 6349542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the altered nucleocytoplasmic transport "in vitro" of rapidly labelled RNA, in the presence of cytosol or serum from tumor-bearing rats.
    Lemaire M; Baeyens W; Baugnet-Mahieu L
    Biomedicine; 1981 Feb; 34(1):47-53. PubMed ID: 6164410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.